Venus Remedies Ltd announced that Saudi Arabia has granted marketing authorization for Docetaxel. Docetaxel is chemotherapy drug used widely.
The announcement comes three months after the company received Saudi Food and Drug Authority (SFDA) certification for all of its production facilities at its Baddi, Himachal Pradesh, unit.
The company said that demand for Docetaxel has been increasing steadily around the world owing to the rising incidence of prostate, breast, stomach, and non-small cell lung cancers. This chemotherapy drug is used as a first line of treatment for such diseases.
According to the study, docetaxel-based treatment has improved survival rates in men with castration-sensitive prostate cancer.
The global Docetaxel market is expected to grow to USD 184 billion by 2030, at a CAGR of 10.22%, stated the report.
Venus Remedies has recently been consolidating its position in the oncology space. Venus Pharma GmbH, Venus Remedies' German subsidiary, has received authorization for marketing from the UK for the key chemotherapy drug Cisplatin. Thus, the process of registering its oncology products in many other countries that look to the UK as a reference point for fast-tracking registration is accelerated.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.